Anti‑Herpes Virus Drugs
Introduction / Overview Herpes simplex viruses (HSV‑1 and HSV‑2) and varicella‑zoster virus (VZV) are ubiquitous pathogens that establish lifelong latency following primary…
Topic Archive
Introduction / Overview Herpes simplex viruses (HSV‑1 and HSV‑2) and varicella‑zoster virus (VZV) are ubiquitous pathogens that establish lifelong latency following primary…
1. Introduction Definition and Overview Anti‑human immunodeficiency virus (HIV) therapy encompasses a variety of pharmacologic classes that interfere with distinct stages of…
Introduction/Overview Human immunodeficiency virus (HIV) remains a significant global health challenge, with antiretroviral therapy (ART) transforming a once fatal disease into a…
Introduction / Overview Brief Introduction to the Topic Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections represent significant global health…
Introduction Malaria remains a global public health challenge, with Plasmodium falciparum and Plasmodium vivax constituting the majority of clinical cases. Antimalarial therapy…
Introduction Anthelminthic agents directed against nematodes constitute a pivotal component of parasitology and clinical pharmacotherapy. The term “anthelminthic” derives from the Greek…
Introduction Definition and Overview Monoclonal antibodies (mAbs) are homogeneous populations of immunoglobulins derived from a single B‑cell clone. They possess a single…
Introduction/Overview Brief Introduction Calcineurin inhibitors (CNIs) represent a pivotal class of immunosuppressive agents widely employed in transplantation medicine and the management of…
Introduction/Overview Multidrug‑resistant tuberculosis (MDR‑TB) presents a significant public health challenge worldwide, necessitating the use of second‑line antitubercular agents. These drugs are employed…
Introduction/Overview Mycobacterium leprae is the etiologic agent of leprosy, a chronic infectious disease that predominantly affects the skin, peripheral nerves, and mucosa…